Cognitive Impairment and Cardiovascular Risk in Older

Cognitive Impairment Clinical Trial

— DECRIVAM  

Official title:

Detection of Mild Cognitive Impairment in People Older Than 65 Years of Age and Its Relationship to Cardiovascular Risk Factors (DECRIVAM)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01327196
• Other study ID #: BIO39/SA04/10
• Status: Completed
• Start date: June 2010
• Est. completion date: December 2012

Study information

• Verified date: September 2014
• Source: Fundacion para la Investigacion y Formacion en Ciencias de la Salud
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The objective of this project is to study cognitive yields in people of the town of Salamanca over 65, with particular emphasis on the acquisition of the initial symptoms of cognitive impairment in order to detect mild cognitive impairment and study the relationship between the clinical situation and cardiovascular risk factors. It will depart from a reference population of 420 people older than 65 years living in the municipality of Salamanca which took part in a survey prior to partner health needs of the elderly of 65 years in the municipality of Salamanca. This was a stratified sampling as stratum considering the area of health. The results of this study are expected to evidence the extent of the problem of cognitive decline in the population over 65 years. It is also expected to determine the relationship between the co-morbidity in this problem and specific factors of cardiovascular risk in this group of population.

Description:

A random sample population, the information obtained has a validity superior to other studies in which the sample has not followed very strict criteria of selection.

Protocol for measurement:

• variable demographic partner

• vascular risk factors

• co-morbidity

• functional level for the activities of daily life

• cognitive performance in attention, memory, language, praxias, gnosias (abbreviated neuropsychological battery)

Through a battery short neuropsychological specially adapted for the study of older people will carry out a study of the cognitive performance in people older than 65 years of age and will try to establish how much influence the controlled variables of cardiovascular risk.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 327
• Est. completion date: December 2012
• Est. primary completion date: June 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• lives in the municipality of Salamanca

• over 65 years of age

Related Conditions & MeSH terms

• Cardiovascular Risk Factor
• Cognitive Dysfunction
• Cognitive Impairment

Locations

Country	Name	City	State
Spain	Fundacion INFOSALUD	Salamanca

Sponsors (2)

Lead Sponsor	Collaborator
Fundacion para la Investigacion y Formacion en Ciencias de la Salud	Grupo de Investigación de Atención Primaria de Castilla y León

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	neuropsychological assessment		neuropsychological assessment
Primary	Prevalence of risk factors cardiovascular		Prevalence of risk factors cardiovascular
Secondary	neuropsychological assessment		neuropsychological assessment

External Links

•   Unidad de Investigación Centro de Salud La Alamedilla